UNSPSC 51422215: Triamcinolone diacetate

This classification denotes a therapeutic glucocorticoid with the molecular formula C25H31FO8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A73MM2Q32P, chemically known as 16alpha,21-diacetoxy-9alpha-fluoro-11beta,17alpha-dihydroxy-1,4-pregnadiene-3,20-dione but more generally known as triamcinolone diacetate, which bears US NIH Compound Identifier 6216. European Medicines Agency schedules Triamcinolone diacetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04938MIG.

UNSPSC 51422215 Triamcinolone diacetate is a Commodity code that shows little relevant recent activity aligned with its nominal scope. The single recent state and local opportunity tagged to this code — Seminole County, Florida's IFB60459723LAS — solicits naloxone and drug deactivation systems, which falls outside the pharmaceutical steroid class the code nominally describes. The mismatch suggests either a tagging error in the jurisdiction's procurement system or a narrow, specialized application of the code that does not reflect typical state and local demand for triamcinolone diacetate products.

Seminole County issued the naloxone procurement as an IFB with a response deadline of July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with a one-year renewal option and includes FEMA compliance requirements. Without additional recent opportunities under this code from other state and local buyers, the available evidence does not support active or broad pursuit at this time.